澳大利亚和新西兰肾移植受者感染相关死亡率研究
该研究基于澳大利亚和新西兰1997-2015年首次肾移植受者登记数据,评估感染相关死亡率及其相关因素。共纳入12,519例患者,感染相关死亡率为45.8/10,000患者年,随时间下降,但仍显著高于年龄匹配的一般人群(SIR 7.8)。危险因素包括高龄、女性、原住民、T细胞清除治疗及尸体供肾。
要点
- 肾移植受者感染相关死亡风险是一般人群的7.8倍
- 感染相关死亡率从1997-2000年的53.1降至2011-2015年的43.9/10,000患者年
- 活体供肾与感染相关死亡风险降低相关(SHR 0.53)
核心结论
- 肾移植受者感染相关死亡率显著高于一般人群,但随时间下降。
研究设计与样本
- 基于登记的回顾性纵向队列研究,纳入1997-2015年澳大利亚和新西兰首次肾移植受者12,519例。
主要发现
- 中位年龄46岁,63%男性,15%糖尿病,6%原住民;2197例(18%)死亡,其中416例(19%)死于感染。
- 感染相关死亡率为45.8(95%CI 41.6-50.4)/10,000患者年,从1997-2000年的53.1(95%CI 45.0-62.5)降至2011-2015年的43.9(95%CI 32.5-59.1)/10,000患者年(P<0.001)。
- 与年龄匹配一般人群相比,标准化发病率比为7.8(95%CI 7.1-8.6)。
- 危险因素:年龄≥60岁(SHR 4.16,95%CI 2.15-8.05,参照20-30岁)、女性(SHR 1.62,95%CI 1.19-2.29)、原住民(SHR 2.87,95%CI 1.84-4.46,参照白人)、2011-2015年移植(SHR 0.39,95%CI 0.20-0.76,参照1997-2000年)、T细胞清除治疗(SHR 2.43,95%CI 1.36-4.33)。
- 活体供肾与感染相关死亡风险降低相关(SHR 0.53,95%CI 0.37-0.76)。
临床怎么用
- 对高龄、女性、原住民、接受T细胞清除治疗或尸体供肾的肾移植受者,应加强感染预防和监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The burden of infectious disease is high among kidney transplant recipients because of concomitant immunosuppression. In this study the incidence of infectious-related mortality and associated factors were evaluated. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this registry-based retrospective, longitudinal cohort study, recipients of a first kidney transplant in Australia and New Zealand between 1997 and 2015 were included. Cumulative incidence of infectious-related mortality was estimated using competing risk regression (using noninfectious mortality as a competing risk event), and compared with age-matched, populated-based data using standardized incidence ratios. RESULTS: Among 12,519 patients, (median age 46 years, 63% men, 15% diabetic, 6% Indigenous ethnicity), 2197 (18%) died, of whom 416 (19%) died from infection. The incidence of infection-related mortality during the study period (1997-2015) was 45.8 (95% confidence interval [95% CI], 41.6 to 50.4) per 10,000 patient-years. The incidence of infection-related mortality reduced from 53.1 (95% CI, 45.0 to 62.5) per 10,000 person-years in 1997-2000 to 43.9 (95% CI, 32.5 to 59.1) per 10,000 person-years in 2011-2015 (P<0.001) Compared with the age-matched general population, kidney transplant recipients had a markedly higher risk of infectious-related death (standardized incidence ratio, 7.8; 95% CI, 7.1 to 8.6). Infectious mortality was associated with older age (≥60 years adjusted subdistribution hazard ratio [SHR], 4.16; 95% CI, 2.15 to 8.05; reference 20-30 years), female sex (SHR, 1.62; 95% CI, 1.19 to 2.29), Indigenous ethnicity (SHR, 2.87; 95% CI, 1.84 to 4.46; reference white), earlier transplant era (2011-2015: SHR, 0.39; 95% CI, 0.20 to 0.76; reference 1997-2000), and use of T cell-depleting therapy (SHR, 2.43; 95% CI, 1.36 to 4.33). Live donor transplantation was associated with lower risk of infection-related mortality (SHR, 0.53; 95% CI, 0.37 to 0.76). CONCLUSIONS: Infection-related mortality in kidney transplant recipients is significantly higher than the general population, but has reduced over time. Risk factors include older age, female sex, Indigenous ethnicity, T cell-depleting therapy, and deceased donor transplantation. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_08_27_CJN03200319.mp3.
引用
- Chan S, Pascoe EM, Clayton PA, et al. Infection-Related Mortality in Recipients of a Kidney Transplant in Australia and New Zealand. Clin J Am Soc Nephrol. 2019. PMID: 31455690. doi:10.2215/CJN.03200319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。